Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 11/30/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 11/17/21
End: 12/03/22
Due: 12/03/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects | NCT02546635 | Artax Biopharma Inc | user2@example.com | None | 2015-08-31 | 2016-01-31 | 2017-01-31 | - | - | 2025-07-14 |
| Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis | NCT05725057 | Artax Biopharma Inc | user2@example.com | None | 2023-11-30 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Safety Study of Immune System Modulator for Autoimmune Diseases | NCT02243683 | Artax Biopharma Inc | user2@example.com | None | 2014-09-30 | 2015-03-31 | 2016-03-31 | - | - | 2025-07-14 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses | NCT05218434 | Artax Biopharma Inc | user2@example.com | None | 2021-11-17 | 2022-12-03 | 2023-12-03 | - | - | 2025-07-14 |